Thousands of Australians contribute to OUTBREAK

Thousands of Australians contribute to OUTBREAK

Developing the right tools to identify and fight antimicrobial resistance across Australia will use insights from the largest cohort study in the Southern Hemisphere. Analysis of data collected over the past 15 years through the Sax Institute’s 45 and Up Study is set...
Getting to the guts of the matter

Getting to the guts of the matter

OUTBREAK industry partner Microba is a Brisbane-based biotech company that specialises in analysing microbial genomics, specifically – gut bacteria. Dr Ken McGrath is Microba’s Technology Liaison Manager… Q: What is your role with OUTBREAK? My background is...
Success built on social licence

Success built on social licence

Professor Mitch Byrne leads the social and behavioural team within OUTBREAK’s Ethical, Legal and Social Implications stream. The team’s focus is on developing and maintaining community acceptance and a social licence for OUTBREAK to operate. Q: Human behaviour is such...
Pharmacists in the box seat to battle AMR

Pharmacists in the box seat to battle AMR

Australian pharmacists are in the box seat to play a major role in the fight against antibiotic-resistant superbugs, according to Dr Lisa Pont who is leading the Prescribing and Health Outcomes stream for OUTBREAK. Research shows patients see their GP on average six...
Public information key to combatting rising superbug threat

Public information key to combatting rising superbug threat

With predictions that drug-resistant superbugs’ could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics. The rise of superbugs, which claimed the lives of an estimated 700,000 people...